Speak directly to the analyst to clarify any post sales queries you may have.
The hernia repair devices market is undergoing rapid transformation as innovative materials, advanced surgical techniques, and shifting healthcare standards redefine how leading organizations manage treatment options, cost structures, and long-term patient outcomes.
Market Snapshot: Hernia Repair Devices Market Growth and Outlook
The hernia repair devices market grew from USD 6.49 billion in 2024 to USD 6.93 billion in 2025. Sustained by a compound annual growth rate (CAGR) of 7.01%, it is projected to reach USD 11.16 billion by 2032. This progression signals robust expansion, underlined by global increases in surgical procedures, advancements in biocompatible meshes, and widespread integration of robotic-assisted techniques—key drivers shaping both patient care and operational strategies for industry stakeholders.
Scope & Segmentation
- Product Categories: Fixation devices, mesh (biological and synthetic mesh), sutures (absorbable and non-absorbable).
- Hernia Types: Femoral, hiatal, inguinal, and ventral hernias. Within ventral: epigastric, incisional, and umbilical hernias.
- Procedure Types: Laparoscopic surgery, open surgery, robotic surgery.
- Patient Types: Adult and pediatric applications, each requiring tailored device specifications.
- End User Environments: Hospitals, clinics, ambulatory surgical centers.
- Regional Analysis: Americas (including North America and Latin America), Europe, Middle East & Africa, and Asia-Pacific. Territories include the United States, Germany, Japan, India, Brazil, China, South Africa, and others, ensuring a nuanced view of global and regional market movements.
- Leading Companies: AbbVie, Aran Biomedical by Integer Holdings, B. Braun, Baxter International, Becton, Dickinson and Company, Boston Scientific, Coloplast, Intuitive Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Zimmer Biomet, and more. Their collective focus spans R&D, manufacturing, clinician education, and integration of digital health solutions within hernia repair device portfolios.
Key Takeaways for Decision-Makers
- Material science advances, including biocompatible polymers and resorbable meshes, support ongoing improvements in surgical outcomes and post-operative recovery profiles.
- Cross-functional collaboration between biomedical engineers and surgeons is accelerating the development of mesh coatings and suturing methods that reduce inflammation and healing times.
- Widespread adoption of robotic-assisted platforms and advanced imaging tools has enhanced operative consistency, enabling precise device placement and reducing adverse event risks.
- Hybrid surgical techniques and the customization of mesh geometry are increasing, responding to a shift toward more personalized patient care.
- Manufacturers are responding to changing economic and regulatory conditions by refining procurement strategies and implementing lean manufacturing to maintain competitiveness.
- Clinical training programs, digital monitoring platforms, and smart implants are being leveraged by industry leaders to drive procedural adoption, gather outcome data, and maintain competitive positions.
Tariff Impact: Navigating Operational Shifts
Recent tariff reforms in the United States have impacted component sourcing, prompting firms to diversify supply chains and expand domestic production capabilities. This has translated to more complex pricing negotiations, a move toward nearshoring, and the broad implementation of value engineering to manage cost fluctuations and ensure business continuity.
Methodology & Data Sources
This report synthesizes primary insights from interviews and surveys with surgeons, procurement leaders, and supply chain executives across various markets. Supplementary analysis is performed using secondary research from peer-reviewed publications, regulatory filings, market intelligence studies, and quantitative statistical validation to ensure accurate, actionable insights.
Why This Report Matters
- Equip senior leaders to make informed decisions by clarifying innovation trends, regulatory changes, and clinical preferences across regional markets.
- Support strategic planning for product development, operational resiliency, and competitive positioning in a rapidly evolving surgical device environment.
- Facilitate the alignment of R&D, procurement, and commercial teams through a granular understanding of segmentation and market entry strategies.
Conclusion
This analysis illuminates the interconnected factors shaping the hernia repair devices market, offering senior decision-makers empirical guidance to optimize resources, streamline innovation, and adapt to emerging industry challenges.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Hernia Repair Devices market report include:- AbbVie Inc.
- Aran Biomedical by Integer Holdings Corporation
- B. Braun SE
- Baxter International Inc.
- Becton, Dickinson and Company
- Betatech Medical
- BioCer Entwicklungs-GmbH
- Boston Scientific Corporation
- Coloplast A/S
- CooperSurgical, Inc.
- Cousin Surgery
- Deep Blue Medical Advances, Inc.
- Dolphin Sutures
- Getinge AB
- HERNIAMESH S.r.l.
- Hwainmedi Co., Ltd.
- Insightra Medical Inc.
- Integra LifeSciences Holdings Corporation
- Intuitive Surgical, Inc.
- Johnson & Johnson Services, Inc.
- KATSAN Katgüt Sanayi ve Tic. A.Ş.
- Medtronic PLC
- Meril Life Sciences Pvt. Ltd.
- Momentis Surgical Ltd.
- Novus Scientific AB
- Olympus Corporation
- Secant Group, LLC
- Surgimatix, Inc.
- TELA Bio, Inc.
- W. L. Gore & Associates, Inc.
- Zimmer Biomet Holdings, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 6.93 Billion |
| Forecasted Market Value ( USD | $ 11.16 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |


